» Articles » PMID: 36974082

Community Socioeconomic Status and Rural/racial Disparities in HPV-/+ Head and Neck Cancer

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Head and Neck Cancer (HNC) is a major cause of cancer morbidity and mortality in the United States, but the burden is not evenly distributed. Rural and racial disparities are obvious across the HNC continuum. Most HNC disparities research have emphasized individual factors perpetuating rural and racial disparities, ignoring the role of community-level factors.

Methods: We analyzed data from the Surveillance Epidemiology and End Results (SEER) program's "Specialized HNC-Human Papillomavirus (HPV) Census-Tract SES" datafile (2010-2016). In addition to cancer patient characteristics, this data includes a socioeconomic status (SES) quintile based on the patient's census-tract. Our outcome variables included whether the HNC patient 1) was diagnosed at a distant stage, 2) received initial treatment two or more months after diagnosis, 3) received radiation therapy, 4) survived two years after diagnosis. We tested for differences across SES quintiles, in the full sample and then within rural/racial categories. We then tested for differences between each rural/racial category conditional on SES quintile.

Results: For both HPV(-) and HPV + HNCs, patients in higher SES census-tracts have 8-10% lower rates of distant stage diagnoses and delayed treatment initiation, and 12.0-14.5% higher survival rates than patients in lower SES census-tracts. Radiation treatment only varied across SES quintiles in HPV + HNC patients. We find little evidence of rural-urban differences within each socioeconomic quintile. However, within lower SES quintiles, we found significant racial disparities in delayed detection and treatment. These differences were largest in the lowest SES quintile, as non-Hispanic Black patients reported 10-11% higher rates of delayed detection and treatment initiation than non-Hispanic White patients.

Conclusions: Our research illustrates the value and constraints in leveraging community-level factors in health disparities research that can ultimately assist in designing effective policies that address and achieve rural and racial cancer equity.

Citing Articles

Head and Neck Cancer Symptoms and Risk Factors Awareness and Effectiveness of Educational Intervention for Underserved Populations.

Zeitouni J, Millsap J, May H, Jang W, Dundar Y OTO Open. 2025; 9(1):e70089.

PMID: 40061294 PMC: 11886989. DOI: 10.1002/oto2.70089.


Multilevel Disparities of Sex-Differentiated Human Papilloma Virus-Positive Oropharyngeal Cancers in the United States.

Verma R, Fei-Zhang D, Fletcher L, Fleishman S, Chelius D, Sheyn A J Clin Med. 2024; 13(21).

PMID: 39518530 PMC: 11546109. DOI: 10.3390/jcm13216392.


Eliminating Medicaid dental benefits and early-stage oral cancer diagnoses.

Semprini J, Reynolds J, Zahnd W, Wehby G Cancer Med. 2024; 13(4):e7061.

PMID: 38457253 PMC: 10923030. DOI: 10.1002/cam4.7061.

References
1.
Megwalu U . Impact of County-Level Socioeconomic Status on Oropharyngeal Cancer Survival in the United States. Otolaryngol Head Neck Surg. 2017; 156(4):665-670. DOI: 10.1177/0194599817691462. View

2.
Gourin C, Podolsky R . Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope. 2006; 116(7):1093-106. DOI: 10.1097/01.mlg.0000224939.61503.83. View

3.
Yu M, Tatalovich Z, Gibson J, Cronin K . Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control. 2013; 25(1):81-92. DOI: 10.1007/s10552-013-0310-1. View

4.
Schlichting J, Pagedar N, Chioreso C, Lynch C, Charlton M . Treatment trends in head and neck cancer: Surveillance, Epidemiology, and End Results (SEER) Patterns of Care analysis. Cancer Causes Control. 2019; 30(7):721-732. PMC: 6668728. DOI: 10.1007/s10552-019-01185-z. View

5.
Mazul A, Naik A, Zhan K, Stepan K, Old M, Kang S . Gender and race interact to influence survival disparities in head and neck cancer. Oral Oncol. 2020; 112:105093. DOI: 10.1016/j.oraloncology.2020.105093. View